Browse Pet Safety Reports
17,908 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 17,908 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product — widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 17,908 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Oct 1, 2024 | Horse | Quarter Horse | MSK | Abnormal radiograph finding; Claw / hoof / nail disorder NOS; Osteomyelitis | Outcome Unknown |
| Oct 1, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Ongoing |
| Oct 1, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Oct 1, 2024 | Horse | Horse (unknown) | MSK | Sickness; Colic | Outcome Unknown |
| Oct 1, 2024 | Horse | Thoroughbred | MSK | Injection site hair change; Hypertrichosis | Outcome Unknown |
| Oct 1, 2024 | Horse | Horse (unknown) | MSK | Gastric ulcer; Other abnormal test result NOS | Outcome Unknown |
| Oct 1, 2024 | Horse | Warmblood (unspecified) | MSK | Muscle atrophy (see also Muscle wasting) | Outcome Unknown |
| Oct 1, 2024 | Horse | Horse (unknown) | MSK | Heavy breathing | Outcome Unknown |
| Oct 1, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Ongoing |
| Sep 30, 2024 | Horse | Thoroughbred | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Sep 30, 2024 | Horse | Oldenburg | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Sep 30, 2024 | Horse | Arab | MSK | Hives (see also Skin) | Outcome Unknown |
| Sep 29, 2024 | Horse | Thoroughbred | MSK | Death by euthanasia; DEATH-TREATMENT FAILURE | Euthanized |
| Sep 28, 2024 | Horse | Horse (unknown) | MSK | Mammary gland oedema | Outcome Unknown |
| Sep 27, 2024 | Horse | Arab | MSK | Hepatitis | Ongoing |
| Sep 26, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Sep 25, 2024 | Horse | Arab, Horse (unknown) | MSK | Injection site swelling | Recovered/Normal |
| Sep 24, 2024 | Horse | Thoroughbred | MSK | Flatulence; Depression; Anorexia; Soft stool; Hypersalivation; Trembling; Ton... | Recovered/Normal |
| Sep 24, 2024 | Horse | Paint | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Sep 23, 2024 | Horse | Quarter Horse | MSK | Hypersalivation; Trembling; Lying down; Depression; Tongue disorder NOS; Diar... | Recovered/Normal |
| Sep 23, 2024 | Horse | Paint, Thoroughbred | MSK | Hives (see also Skin); Facial swelling (see also Skin); Swollen limb | Recovered/Normal |
| Sep 23, 2024 | Horse | Tennessee Walking Horse | MSK | Swollen muzzle; Preputial swelling; Colic | Ongoing |
| Sep 22, 2024 | Horse | Horse (other) | MSK | Mouth blister; Swollen lip (see also Skin); Swollen tongue; Colic | Recovered/Normal |
| Sep 21, 2024 | Horse | Tennessee Walking Horse | MSK | Lack of efficacy (protozoa) - NOS | Ongoing |
| Sep 21, 2024 | Horse | Horse (unknown) | MSK | Fasciculation; Increased packed cell volume (PCV); Abnormal ultrasound findin... | Recovered/Normal |
| Sep 20, 2024 | Horse | Horse (unknown) | MSK | Aggression | Recovered/Normal |
| Sep 20, 2024 | Horse | Paint | MSK | Seizure NOS; Wound | Outcome Unknown |
| Sep 20, 2024 | Horse | Quarter Horse | MSK | Heavy sweating; Medication error NOS; Administration error NOS | Recovered/Normal |
| Sep 19, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Sep 19, 2024 | Horse | Holsteiner | MSK | Injection site abscess; Neutrophilia; Abnormal serum protein NOS; Abnormal cy... | Recovered/Normal |
| Sep 18, 2024 | Horse | Warmblood (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Sep 18, 2024 | Horse | Warmblood (unspecified) | MSK | Sedation prolonged; Behavioural disorder NOS; Colic; Uncomfortable; Quiet; Ly... | Ongoing |
| Sep 17, 2024 | Horse | Holsteiner | MSK | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy; Drug administration ... | Recovered/Normal |
| Sep 17, 2024 | Horse | Pony of the Americas | MSK | Injection site swelling; Hives (see also Skin); Hypersensitivity NOS | Recovered/Normal |
| Sep 17, 2024 | Horse | Horse (other) | MSK | Application site swelling | Recovered/Normal |
| Sep 17, 2024 | Horse | National Show Horse | MSK | Mammary gland disorder NOS | Ongoing |
| Sep 16, 2024 | Horse | Trakehner | MSK | Lack of efficacy - NOS | Ongoing |
| Sep 16, 2024 | Horse | Quarter Horse | MSK | Mammary gland disorder NOS | Ongoing |
| Sep 12, 2024 | Horse | Warmblood (unspecified) | MSK | Sedation prolonged | Recovered/Normal |
| Sep 12, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Euthanized |
| Sep 12, 2024 | Horse | Arab | MSK | Anaphylactic-type reaction; Tachypnoea; Excessive sweating; Anxiety; Inappete... | Recovered/Normal |
| Sep 12, 2024 | Horse | Rocky Mountain Horse | MSK | Recumbency; Stiff gait; Muscle pain | Outcome Unknown |
| Sep 12, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Outcome Unknown |
| Sep 11, 2024 | Horse | Appaloosa | MSK | Lack of efficacy (bacteria) - NOS; Lying down; Diarrhoea; Pain NOS | Recovered/Normal |
| Sep 11, 2024 | Horse | Paint | MSK | Hair coat discolouration | Outcome Unknown |
| Sep 11, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Sep 11, 2024 | Horse | Quarter Horse | MSK | Lack of efficacy - NOS | Ongoing |
| Sep 11, 2024 | Horse | Pony (unspecified) | MSK | Lack of efficacy - NOS | Ongoing |
| Sep 10, 2024 | Horse | Horse (unknown) | MSK | Lack of efficacy - NOS | Recovered/Normal |
| Sep 10, 2024 | Horse | Warmblood - Dutch | MSK | Sedation prolonged; Facial oedema; Partial anorexia | Recovered/Normal |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe — difficulty breathing, seizures, collapse, or severe swelling — seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.